DOTA-LM3 TFA – High Purity 99.30% – GMP Manufacturer

DOTA-LM3 TFA – High Purity 99.30% – GMP Manufacturer

$2.00

DOTA-LM3 TFA is a high-purity (99.30%) somatostatin receptor (SSTR) antagonist peptide, manufactured under GMP standards. It is utilized in tumor tracing and radionuclide-drug conjugate research. For laboratory research use only.?For wholesale prices, other specifications and uses, please consult our staff?

EMI starting from $0.00/month - View Plans
Compare
Category:

Description

DOTA-LM3 TFA is a synthetic peptide designed as a somatostatin receptor (SSTR) antagonist. The LM3 sequence refers to p-Cl-Phe-cyclo(D-Cys-Tyr-D-4-amino-Phe(carbamoyl)-Lys-Thr-Cys)D-Tyr-NH?. This peptide is often isotopically labeled for in vivo tumor tracing, such as with 177Lu-DOTA-LM3 TFA and 68Ga-DOTA-LM3 TFA.

  • 177Lu-DOTA-LM3 TFA is utilized in research on DOTATOC-negative liver metastases, including pancreatic neuroendocrine tumors (NETs) and extensive tumor thrombosis.

  • 68Ga-DOTA-LM3 TFA exhibits favorable biodistribution, high tumor uptake, good tumor retention, and minimal safety concerns.

DOTA-LM3 TFA is also employed in the synthesis and research of Radionuclide-Drug Conjugates (RDCs), offering potential in targeted cancer therapies.

Manufactured under GMP standards with a purity of 99.30%, DOTA-LM3 TFA ensures consistency and reliability for experimental use.


Product Specifications

ParameterDetails
Product NameDOTA-LM3 TFA
SynonymsLM3 TFA, p-Cl-Phe-cyclo(D-Cys-Tyr-D-4-amino-Phe(carbamoyl)-Lys-Thr-Cys)D-Tyr-NH?
CAS No.1192362-32-5
Purity99.30% (GMP-grade)
Molecular FormulaC??H??ClF?N??O??S?
Molecular Weight1664.18 g/mol
AppearanceWhite to off-white powder
SolubilitySoluble in water and DMSO
Storage ConditionsStore at –20?°C, protect from light and moisture
ApplicationsTumor tracing, Radionuclide-Drug Conjugate research
Regulatory StatusFor laboratory research use only

Mechanism of Action & Research Applications

Mechanism of Action:
DOTA-LM3 TFA functions as a somatostatin receptor (SSTR) antagonist. The LM3 peptide sequence is designed to bind to SSTRs, inhibiting their activity and providing a means to trace tumors in vivo when isotopically labeled.

Research Applications:

  • Tumor Tracing: Utilizing isotopically labeled DOTA-LM3 TFA (e.g., 177Lu-DOTA-LM3 TFA, 68Ga-DOTA-LM3 TFA) for imaging and locating tumors.

  • Radionuclide-Drug Conjugates (RDCs): Employing DOTA-LM3 TFA in the development of targeted therapies combining radionuclides and drugs.

    images-dota-lm3-tfa-oxidized-formula


Side Effects (Research Context Only)

DOTA-LM3 TFA is intended for laboratory research use only. In preclinical studies, it has been shown to exhibit favorable biodistribution and tumor uptake with minimal safety concerns. However, as with all experimental compounds, appropriate safety protocols should be followed during handling and administration.


Disclaimer

DOTA-LM3 TFA is strictly for laboratory research use only. It is not approved for clinical, diagnostic, or therapeutic purposes. Users should adhere to institutional safety guidelines and regulatory requirements when handling this compound.

Additional information

Weight0.6 kg
Dimensions36 × 23 × 36 cm

Reviews

There are no reviews yet.

Be the first to review “DOTA-LM3 TFA – High Purity 99.30% – GMP Manufacturer”

Your email address will not be published. Required fields are marked *

EMI Options

Select at least 2 products
to compare